GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/Laparoscopic vs Open Adhesiolysis for Bowel Obstruction: JAMA Surgery | June 2026
7

Laparoscopic vs Open Adhesiolysis for Bowel Obstruction: JAMA Surgery | June 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated June 1, 2026

Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the first randomized evidence comparing these two approaches.

Why was this study needed?

  • Long-term outcomes after laparoscopic adhesiolysis have not been well established.
  • Previous studies have largely focused on short-term recovery.
  • Whether laparoscopy reduces recurrent bowel obstruction remains unclear.
  • Evidence from randomized controlled trials has been lacking.
  • Long-term patient-centered outcomes are important when selecting the surgical approach.

Results:

  • Recurrence of small bowel obstruction was similar after laparoscopic and open adhesiolysis over 1.5 years of follow-up.
  • Quality of life and incisional hernia rates did not differ between the two surgical approaches.
  • The study found no long-term advantage of laparoscopy over open adhesiolysis.

Clinical Impact:

While laparoscopy may still provide short-term benefits in carefully selected patients, surgeons should not expect improved long-term outcomes regarding recurrence, quality of life, or incisional hernia. The choice of approach should therefore be guided by patient characteristics, surgeon expertise, and intraoperative findings.

Bottom Line:

The LASSO trial—the first randomized study in this field—demonstrates that laparoscopic adhesiolysis offers no significant long-term advantage over open surgery for adhesive small bowel obstruction. Short-term benefits remain important, but long-term outcomes are comparable.

Related Q&A

08

DPP-4 Inhibition Targets the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026

Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether...

09

Bedside Ultrasound Outperforms Abdominal X-Ray in Neonatal Necrotizing Enterocolitis: Frontiers in Pediatrics | July 2026

Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study...

10

Common Drugs and Clostridioides difficile Infection: Gut | July 2026

Introduction: Antibiotic exposure is the best-established risk factor for Clostridioides difficile infection (CDI). However, the contribution of many commonly prescribed non-antibiotic medications has remained uncertain. This large Swedish...

11

Seated Anorectal Manometry Better Predicts Balloon Expulsion Success: AJG |June 2026

Dyssynergic defecation is commonly evaluated using anorectal manometry, traditionally performed in the left lateral decubitus position. However, defecation normally occurs in the seated position, raising questions about whether...

12

DOTATATE PET in Poorly Differentiated Extrapulmonary NEC: JNM | June 2026

Somatostatin receptor (SSTR) imaging with ⁶⁸Ga-DOTATATE PET is a cornerstone for well-differentiated neuroendocrine tumors, but its role in poorly differentiated neuroendocrine carcinoma (NEC) has remained uncertain. Previous retrospective...

13

F. prausnitzii Counters CRC Progression : Gastroenterology | Jun 2026

Introduction: The gut microbiome plays a central role in colorectal cancer (CRC) development, influencing inflammation, metabolism, immune responses, and tumor behavior. While several microbial species have been implicated...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer